However, we did not see any apparent impact of Mcpt6 deficiency on CD8 expression in the tumors, suggesting that any impact of CXCL9 on tumor progression may be explained by effects beyond its influence on CD8+ T‐cell recruitment. Here, CXCL9 is linked to neoplasm.